Elite Pharmaceuticals Inc
ELTP· OTC
Released Feb 17, 2026, after the close
10-Q filed Feb 17, 2026, 48 days after period end · 0001493152-26-007104
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $31.59M | $14.36M | $15.54M | $9.25M |
| Net Income | $18.59M | -$10.89M | $706.35K | $2.97M |
| EPS Diluted |
Elite Pharmaceuticals Inc · CIK 1053369 · Engraved from SEC EDGAR
| $0.01 |
| -$0.01 |
| $0.00 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.